Amphastar P (AMPH) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Over the past 4 years, Amphastar P has achieved a revenue compound annual growth rate (CAGR) of 20.3%, while earnings have grown at 247.3% CAGR.
Historical revenue and profitability trends for Amphastar P
The chart above illustrates Amphastar P's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Amphastar P's business.
How efficiently Amphastar P converts revenue into profit
Profit margins reveal how much of each dollar of revenue Amphastar P retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Amphastar P to continue growing earnings in the coming year. The consensus analyst rating is 3.6667 based on 6 analysts.
Based on our comprehensive analysis, Amphastar P (AMPH) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Amphastar P's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Amphastar P stacks up against similar companies
Explore growth analysis for top stocks
Related: AMPH Valuation, AMPH Dividend, AMPH Financial Health
Compare: AMPH vs AAPL, AMPH vs MSFT, AMPH vs GOOGL